Cardinal Health Inc (CAH) Stock Price & Analysis
Cardinal Health Inc (CAH) rose 4.01% to USD 212.67 as of June 9, 2026 at 22:33 UTC, according to Nexqual real-time market data.
CAH last closed at USD 204.48; the session ranged USD 202.17–212.82 on volume of 2,775,015 shares. Market capitalization is $49.81B, with a 52-week range of USD 137.75–233.6 (NYQ). Source: Nexqual, June 9, 2026 at 22:33 UTC.
Key Statistics (as of June 9, 2026 at 22:33 UTC)
| Price | USD 212.67 |
|---|---|
| Change | ▲ 4.01% (up) |
| Previous Close | USD 204.48 |
| Open | USD 203.24 |
| Day Range | USD 202.17 – 212.82 |
| 52-Week Range | USD 137.75 – 233.6 |
| Volume | 2,775,015 shares |
| Market Cap | $49.81B |
| Exchange | NYQ |
Technical Analysis (CAH)
Nexqual's technical model rates CAH "BUY" based on 5 bullish and 2 bearish signals across 124 daily candles, as of June 9, 2026 at 22:33 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 67.1 (neutral) |
| vs SMA50 | Above (USD 202.14) |
| MACD | 1.52 (positive) |
Analyst Ratings (CAH)
Wall Street analysts rate CAH "Strong Buy" based on 15 analysts, with a mean price target of USD 245.27 (range USD 215–275), per Nexqual as of June 9, 2026 at 22:33 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 15 |
| Mean Target | USD 245.27 |
| High Target | USD 275 |
| Low Target | USD 215 |
| Buy / Hold / Sell | 14 / 3 / 0 |
Earnings (CAH)
| Next Earnings Date | 2026-04-30 |
|---|---|
| EPS Estimate | USD 2.41 |
| Revenue Estimate | $65.14B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 3.17 vs est 2.79 ▲ beat |
| 2025-12-31 | USD 2.63 vs est 2.37 ▲ beat |
| 2025-09-30 | USD 2.55 vs est 2.17 ▲ beat |
| 2025-06-30 | USD 2.08 vs est 2.03 ▲ beat |
Source: Nexqual, June 9, 2026 at 22:33 UTC.
Financials & Fundamentals (CAH)
| Total Revenue | $250.74B |
|---|---|
| Revenue Growth (YoY) | +11.00% |
| Gross Margin | +3.76% |
| Operating Margin | +1.41% |
| Profit Margin | +0.62% |
| Current Ratio | 0.91 |
| Total Cash | $3.94B |
| Total Debt | $8.92B |
| Free Cash Flow | $4.85B |
Source: Nexqual, June 9, 2026 at 22:33 UTC.
Financial Health Score (CAH)
Nexqual rates Cardinal Health Inc's overall financial health "Weak" across five dimensions, as of June 9, 2026 at 22:33 UTC.
| Growth | Weak — Revenue -2% YoY (annual), declining |
|---|---|
| Profitability | Weak — Gross margin 4%, operating 1% |
| Balance Sheet | Mixed — $3.94B cash vs $8.92B debt |
| Cash Flow | Mixed — FCF $4.85B, slim 2.2% margin |
| Efficiency | Mixed — No data |
Ownership (CAH)
| Insider Ownership | +0.26% |
|---|---|
| Institutional Ownership | +89.92% |
| Shares Outstanding | 234.21M |
| Float | 233.73M |
| Short % of Float | +3.66% |
Source: Nexqual, June 9, 2026 at 22:33 UTC.
Leadership (CAH)
Cardinal Health Inc is led by Jason M. Hollar (age 52), CEO & Director, per Nexqual as of June 9, 2026 at 22:33 UTC.
| CEO & Director | Jason M. Hollar (age 52) |
|---|---|
| Chief Financial Officer | Aaron E. Alt (age 53) |
| Vice President of Investor Relations | Matt Sims |
| President of Biopharma Solutions & Strategic Sourcing | Craig Cowman |
| Senior Vice President | Patricia M. English (age 45) |
Major Backers & Investors (CAH)
Notable institutional backers of Cardinal Health Inc include Morgan Stanley, Wellington Management, FMR, LLC, according to Nexqual as of June 9, 2026 at 22:33 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 2.12% |
| Wellington Management | 1.83% |
| FMR, LLC | 1.81% |
| WCM Investment Management, LLC | 1.71% |
| Invesco | 1.5% |
| Fidelity | 1.29% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 22.44% |
| BlackRock | 14.17% |
| State Street | 6.36% |
| Geode Capital | 2.81% |
Source: Nexqual, June 9, 2026 at 22:33 UTC.
From Cardinal Health Inc's Latest SEC 10-K Filing (filed 2025-08-12)
Key Strengths & Strategy (as disclosed to the SEC)
- Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally.
- It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution.
- The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
- It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MCK | McKesson Corporation | USD 784.23 | ▲ 1.1% |
| BDX | Becton, Dickinson and Company | USD 152.04 | ▲ 0.58% |
| BAX | Baxter International Inc. | USD 20.03 | ▲ 3.35% |
| BEN | Franklin Resources, Inc. | USD 31.8 | ▲ 1.5% |
| AFL | AFLAC Incorporated | USD 115.61 | ▼ 2.22% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 22:33 UTC. This page is informational and not investment advice.